treatment advances in achieving remission in mild to moderate ulcerative colitis
DESCRIPTION
Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis. Goals of Therapy for Patients With UC. Sequential Therapies for UC. Oral 5-ASA Formulations: Sites of Delivery. Conventional Corticosteroids in UC. Corticosteroids: Dependency — Short- and Long-term Efficacy. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/1.jpg)
Treatment Advances in Achieving Remission in Mild to
Moderate Ulcerative Colitis
![Page 2: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/2.jpg)
Goals of Therapy for Patients With UC
![Page 3: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/3.jpg)
Sequential Therapies for UC
![Page 4: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/4.jpg)
Oral 5-ASA Formulations: Sites of Delivery
![Page 5: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/5.jpg)
Conventional Corticosteroids in UC
![Page 6: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/6.jpg)
Corticosteroids: Dependency—Short- and Long-term Efficacy
![Page 7: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/7.jpg)
CORE I and II: Budesonide MMX Primary End Point: Combined Clinical and Endoscopic
Remission
![Page 8: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/8.jpg)
Azathioprine vs 5-ASA for Corticosteroid-Dependent, Active
UC
![Page 9: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/9.jpg)
Anti-TNF Therapies for Moderate to Severe Disease
![Page 10: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/10.jpg)
Treatment Algorithm to Maximize Remission and Minimize
Corticosteroid Dependence in UC
![Page 11: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/11.jpg)
Patient Case
![Page 12: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/12.jpg)
Mesalamine Safety
![Page 13: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/13.jpg)
Patient Case (cont)
![Page 14: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/14.jpg)
Pooled Safety Data: Adverse Effects of Budesonide MMX in Patients With Active UC
![Page 15: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/15.jpg)
Anti-TNF Agents: Adverse Events
![Page 16: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/16.jpg)
Minimizing Toxicity for Anti-TNF Therapy
![Page 17: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/17.jpg)
Summary: Safety
![Page 18: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/18.jpg)
Effect on Bone Density
![Page 19: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/19.jpg)
Monitoring the Patient Receiving Budesonide MMX
![Page 20: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/20.jpg)
Summary: Safety of Agents Used to Induce Remission in Mild to
Moderate UC
![Page 21: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/21.jpg)
Abbreviations
![Page 22: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/22.jpg)
References
![Page 23: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/23.jpg)
References (cont)
![Page 24: Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis](https://reader036.vdocument.in/reader036/viewer/2022062517/56812ef0550346895d948e2b/html5/thumbnails/24.jpg)
References (cont)